The relationship between angiotensin-converting enzyme (insertion/deletion) gene polymorphism and left ventricular remodeling in acute myocardial infarction

Coronary Artery Disease

Volumn 18, Issue 3, 2007, Pages 153-157

  Ulgen, Mehmet S ^a   Ozturk, Onder ^b   Alan, Sait ^b   Kayrak, Mehmet ^a   Turan, Yasar ^a   Tekes, Selehattin ^b   Toprak, Nizamettin ^b  

^a SELCUK UNIVERSITY   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

Author keywords

Angiotensin converting enzyme gene polymorphism; Myocardial infarction; Ventricular remodeling

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD FLOW VELOCITY; DECELERATION; DNA POLYMORPHISM; ECHOCARDIOGRAPHY; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; HEART EJECTION FRACTION; HEART INDEX; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE RELAXATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TIME FACTORS; VENTRICULAR REMODELING;

EID: 34247268466     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328010a4c4     Document Type: Article

References (30)

1. Pfeffer MA. Left ventricular remodeling after acute myocardial infarction. Ann Rev Med 1995; 46:455-466.
2. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M. The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995; 76:326-329.
3. Dostal DE, Baker KM. The cardiac renin-angiotensin system. Conceptual, or a regulator of cardiac function? Circ Res 1999; 85:643-650.
4. Ohmichi N. Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996; 53:265-272.
5. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene: two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem 1991; 266:15377-15383.
6. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 15; 359:641-644.
7. Dakik HA, Mahmarian JJ, Verani MS, Farmer JA, Zhao G, Marian AJ, et al. Association of angiotensin I-converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29:1468-1673.
8. Moller JE, Sondergaard E, Steen H, Egstrup K. The Doppler echocardiographic myocardial performance index predicts left ventricular dilation and cardiac death after myocardial infarction. Cardiology 2001; 95:105-111.
9. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26:357-366.
10. Poulsen SH, Jensen SE, Tei C, Seward JB, Egstrup K. Value of the Doppler index of myocardial performance in the early phase of acute myocardial infarction. J Am Soc Echocardiogr 2000; 13:723-730.
11. HenryWI, De Maria A, Gramiah R, King DL, Kisslo JA, Popp RL, et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in two dimensional imaging. Circulation 1980; 62: 212-217.
12. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene DCP1 dipeptidyl carboxypeptidase 1. Nucleic Acids Res 1992; 20: 1433-1446.
13. Zee RY, Solomon SD, Ajani UA, Pfeffer MA, Lindpaintner K; Heart investigators. A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study. Clin Genet 2002; 61:21-25.
14. Vaughan De, Lazos SA, Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cell: a potential link between the renin angiotensin system and thrombosis. L Clin Invest 1995; 95:995-1001.
15. Someya N, Morotomi Y, Kodama K, Kida O, Higa T, Kondo K. Suppressive effect of captopril on platelet aggregation in essential hypertension. Cardiovasc Pharmacol 1984; 6:840-843.
16. McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988; 60:117-124.
17. Dzau VJ. Cardiac renin-angiotensin system. Molecular and functional aspects. Am J Med 1988; 84:22-27.
18. Davis GK, Millner RW, Roberts DH. Angiotensin converting enzyme (ACE) gene expression in the human left ventricle: effect of ACE gene insertion/ deletion polymorphism and left ventricular function. Eur J Heart Fail 2000; 2:253-256.
19. Dakik HA, Mahmarian JJ, Verani MS, Farmer JA, Zhao G, Marian AJ. Association of angiotensin II- converting enzyme gene polymorphism with myocardial ischemia and patency of infarct-related artery in patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29:1468-1473.
20. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81:1161-1172.
21. Nagashima J, Musha H, So T, Kunishima T, Nobuoka S, Murayama M, et al. Effect of angiotensin converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction. Clin Cardiol 1999; 22:587-590.
22. Pinto YM, van Gilst WH, Kingma JH, Schunkert H. Deletion type allele of the ACE gene is associated with progressive ventricular dilatation after anterior myocardial infarction. Captopril and Thrombolysis Study Investigators. J Am Coll Cardiol 1995; 25:1622-1626.
23. Ledru F, Blanchard D, Battaglia S, Jeunemaitre X, Courbon D, Guize L, et al. Relation between severity of coronary artery disease, left ventricular function, and myocardial infarction, and influence of the ACE I/D gene polymorphism. Am J Cardiol 1998; 82:160-165.
24. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993; 30; 342:85-86.
25. He Y, Tomita Y, Kusama Y, Munakata K, Kishida H, Takano T. A role of angiotensin-converting enzyme gene polymorphism in left ventricular remodeling after myocardial infarction. J Nippon Med Sch 2000; 67: 96-104.
26. Nagashima J, Musha H, So T, Kunishima T, Nobuoka S, Murayama M. Effect of angiotensin-converting enzyme gene polymorphism on left ventricular remodeling after anteroseptal infarction. Clin Cardiol 1990; 22:587-590.
27. Ueda S, Elliott HL, Morton JJ, Connell JMC. Enhanced pressor response to angiotensin I in normotensive men with deletion genotype (DD) for angiotensin-converting enzyme. Hypertension. 1995;25:1266-1269.
28. Takezako T, Zhang B, Serikawa T, Fan P, Nomoto J, Saku K. The D allele of the angiotensin-converting enzyme gene and reperfusion-induced ventricular arrhythmias in patients with acute myocardial infarction. Jpn Circ J 2001; 65:603-609.
29. Pfeffer MA, Greaves SC, Arnold JM, Glynn RJ, LaMotte FS, Lee RT, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation 1997; 95:2643-2651.
30. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2004; 44:E1-E211.